Search

Search Constraints

You searched for: Author/Creator Kang, Jin‐Hyoung

Search Results

1. A Randomized, Multicenter, Phase II Study of Cetuximab With Docetaxel and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Cancer. (24th August 2015)

2. Clinical activity of ASP8273 in Asian patients with non‐small‐cell lung cancer with EGFR activating and T790M mutations. Issue 9 (9th August 2018)

4. Olmutinib in T790M‐positive non–small cell lung cancer after failure of first‐line epidermal growth factor receptor‐tyrosine kinase inhibitor therapy: A global, phase 2 study. Issue 9 (12th January 2021)

5. Prognostic value of 18F‐FDG PET parameters in patients with locally advanced non‐small cell lung cancer treated with induction chemotherapy. Issue 1 (28th November 2019)

6. Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy‐Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10‐21. (28th October 2015)

7. Safety and efficacy of single‐agent docetaxel (Taxotere) administered weekly in non‐small cell lung carcinoma patients in Korea: An observational study. Issue 2 (1st November 2015)

8. Two‐year follow‐up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141). Issue 10 (24th June 2020)